Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Venetoclax is a small molecule drug approved in combination with azacitidine for the treatment of acute myeloid leukemia. Initially indicated as chronic lymphocytic leukemia, it ha···【more】
Article source：Captain MedicineRelease date：2024-08-13Recommended：525
Venetoclax is an oral targeted drug that can effectively inhibit the anti-apoptotic function of BCL-2 protein and restore the normal death of cancer cells. The drug is usually used···【more】
Article source：Captain MedicineRelease date：2024-08-13Recommended：574
Venetoclax is a targeted drug used in the treatment of a variety of hematologic malignancies, mainly by blocking the activity of BCL-2 protein to promote apoptosis of tumor cells. ···【more】
Article source：Captain MedicineRelease date：2024-08-13Recommended：518
Venetoclax is the only approved selective inhibitor of Bcl-2 in the world. By binding Bcl-2 protein with high affinity, Bax/Bak-dependent apoptosis is induced and platelet damage i···【more】
Article source：Captain MedicineRelease date：2024-08-13Recommended：505
As a potent and selective oral inhibitor targeting FGFR subtypes 1/2/3, Pemigatinib provides a new treatment option for cholangiocarcinoma patients.What is the dosage of Pemigatini···【more】
Article source：Captain MedicineRelease date：2024-08-13Recommended：412
Pemigatinib, brand name Damitan, is a potent and selective oral inhibitor against FGFR subtypes 1/2/3.How to use PemigatinibPemigatinibtablets should be swallowed whole, not chewed···【more】
Article source：Captain MedicineRelease date：2024-08-13Recommended：402
Pemigatinibis a small molecule kinase inhibitor targeting the fibroblast growth factor receptor (FGFR), primarily for the treatment of advanced or metastatic cholangiocarcinoma cau···【more】
Article source：Captain MedicineRelease date：2024-08-13Recommended：488
Pemigatinib is indicated for adult patients with advanced, metastatic, or unresectable cholangiocarcinoma with FGFR2 fusion or rearrangement confirmed by testing.What are the suita···【more】
Article source：Captain MedicineRelease date：2024-08-13Recommended：473
Pemigatinib is an innovative targeted therapy that provides a new treatment option for patients with FGFR2 fusion or rearranged cholangiocarcinoma.What diseases is Pemigatinib suit···【more】
Article source：Captain MedicineRelease date：2024-08-13Recommended：518
Pemigatinibis mainly used to treat specific diseases such as advanced or metastatic cholangiocarcinoma caused by FGFR2 fusion or rearrangement.What are the indications for Pemigati···【more】
Article source：Captain MedicineRelease date：2024-08-13Recommended：498
Pemigatinib is used in adults to treat bile duct cancer that has spread to other parts of the body (metastatic) or cannot be removed with surgery. Pemigatinib is usually given afte···【more】
Article source：Captain MedicineRelease date：2024-08-13Recommended：466
Pemigatinib is a targeted therapy drug developed by Incyte in the United States, mainly for the treatment of cholangiocarcinoma, especially in adult patients with previously treate···【more】
Article source：Captain MedicineRelease date：2024-08-12Recommended：438
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】
Recommended：8522025-17-12
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended：10492024-09-07
Recently, Lao Lucius Pharmaceutical (Lucius Pharmaceuticals) issued a solemn statement regarding cou···【more】
Recommended：2982026-10-10
Lucius Pharmaceuticals Version of Vibegron Now Available1.Basic Drug InformationVibegron (generic na···【more】
Recommended：4042026-06-08
In recent years, leveraging the World Trade Organization (WTO) patent waiver for least-developed cou···【more】
Recommended：5962026-05-08
How Can Chinese Patients Access Generic Drugs from Laos?In recent years, generic drugs from Laos hav···【more】
Recommended：5592026-04-08
Lucius Pharmaceuticals version of Ibrutinib is now availableIn a randomized controlled trial of 269 ···【more】
Recommended：4542026-03-08
Leveraging the WTO patent waiver for least-developed countries (extended to 2033), Laos has seen rap···【more】
Recommended：6052026-31-07
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address: No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Name: Lucius
Telegram name: Vira
No.:0085253923643
Telegram name: Vira
No.:0085253923643
